4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-21-022220
Options or other derivatives
- Chief Executive Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trieu Vuong Chief Executive Officer | 2021-09-03 | Grant or award · Stock Options | +225,000 | 225,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…